Investors

Insider Transactions

Date Name Title Type Shares Traded Sorted Descending Price Range
Jul 6, 2009 vagelos p roy Director Disposition (Non Open Market) 11,837 n/a
Jan 6, 2009 vagelos p roy Director Disposition (Non Open Market) 11,771 n/a
Oct 1, 2007 vagelos p roy Director Automatic Sell 11,560 n/a
Nov 13, 2012 goldberg murray a Officer Automatic Sell 11,557 144.36 - 148.05
Mar 21, 2011 goldstein joseph l Director Automatic Sell 11,505 40.00
Nov 27, 2012 roberts william Officer Disposition (Non Open Market) 11,500 n/a
Nov 30, 2012 roberts william Officer Sell 11,500 177.43 - 186.00
Nov 27, 2012 roberts william Officer Acquisition (Non Open Market) 11,500 n/a
Feb 11, 2014 vagelos p roy Officer Automatic Sell 11,475 325.10
May 22, 2014 van plew daniel p Officer Option Execute 11,200 21.25
Dec 16, 2010 goldberg murray a Officer Automatic Sell 11,082 31.80
Dec 16, 2010 goldberg murray a Officer Automatic Sell 11,082 31.80
Jul 1, 2011 baker charles a Director Option Execute 11,000 28.81
Jul 1, 2011 baker charles a Director Automatic Sell 11,000 55.94 - 57.40
Jan 10, 2012 terifay robert j Officer Automatic Sell 10,981 73.92
Jul 26, 2011 powchik peter Officer Automatic Sell 10,977 54.74 - 55.19
Aug 23, 2013 ryan arthur f Director Sell 10,958 238.47
Jan 31, 2014 sanofi Beneficial Owner (10% or more) Buy 10,914 286.13 - 289.90
Oct 5, 2009 vagelos p roy Director Disposition (Non Open Market) 10,796 n/a
Mar 29, 2008 vagelos p roy Director Disposition (Non Open Market) 10,669 n/a
Showing 361-380 of 790 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)